T829-2032 Screening compound: NN2-TRIMETHYL-5-[(PYRIDIN-3-YL)METHYL]-4H5H6H7H-FURO[32-C]PYRIDINE-3-CARBOXAMIDE

T829-2032 Screening compound: NN2-TRIMETHYL-5-[(PYRIDIN-3-YL)METHYL]-4H5H6H7H-FURO[32-C]PYRIDINE-3-CARBOXAMIDE
T829-2032 Screening compound: NN2-TRIMETHYL-5-[(PYRIDIN-3-YL)METHYL]-4H5H6H7H-FURO[32-C]PYRIDINE-3-CARBOXAMIDE alternative view

Chemical Structure Depiction of ChemDiv screening compound T829-2032
NN2-TRIMETHYL-5-[(PYRIDIN-3-YL)METHYL]-4H5H6H7H-FURO[32-C]PYRIDINE-3-CARBOXAMIDE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T829-2032

Molecular Formula

C17H21N3O2 (C17 H21 N3 O2)

Compound Name

NN2-TRIMETHYL-5-[(PYRIDIN-3-YL)METHYL]-4H5H6H7H-FURO[32-C]PYRIDINE-3-CARBOXAMIDE

IUPAC name

NN2-trimethyl-5-[(pyridin-3-yl)methyl]-4H5H6H7H-furo[32-c]pyridine-3-carboxamide

SMILES

Cc1c(C(N(C)C)=O)c(CN(Cc2cnccc2)CC2)c2o1

InChI

InChI=1S/C17H21N3O2/c1-12-16(17(21)19(2)3)14-11-20(8-6-15(14)22-12)10-13-5-4-7-18-9-13/h4-5,7,9H,6,8,10-11H2,1-3H3

InChI Key

YCSNJBHDCNCTEW-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD30463448

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

299.37

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

0.333

Distribution Coefficient, logD

-3.760

Water Solubility, LogSw

-0.50

Polar Surface Area

37.379

Acid Dissociation Constant (pKa)

24.78

Base Dissociation Constant (pKb)

11.49

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

41.18

T829-2032 in Drug Discovery

Included in Screening Libraries

3D-Fragment Library (4274 compounds)

Cardiovascular Library (22201 compounds)

Protein-Protein Interaction Library (218420 compounds)

STING Agonist Library (5895 compounds)

Soluble Diversity Library (15920 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

MDM2-p53 interaction inhibitors Library (21687 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
  • Fragments
  • Cyclic compounds
Therapeutical areas:
  • Cardiovascular
  • Cancer
  • Immune system
  • Cancer
Mechanism of action:
  • PPI modulators
  • PPI modulators
Targets:
  • Others

References: we are preparing a list of scientific research reports with T829-2032 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound T829-2032?
Check Price and Availability of T829-2032, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of T829-2032 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for T829-2032
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for T829-2032
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of T829-2032 available by request